Back to Search
JOHN KIRKWOOD, MD
MD
Specialist
NPI: 1528036449IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
MD037183E(PA)
Education
YALE UNIVERSITY SCHOOL OF MEDICINE
Class of 1973
Research & Publications (20)
Highlights from the perspectives in melanoma XII conference.
PMID 19302131·Pigment Cell Melanoma Res·2009
7-preclinical
Does pegylated interferon alpha-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?
PMID 19092800·Nat Clin Pract Oncol·2009
8-other
Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.
PMID 19228745·Clin Cancer Res·2009
3-trial
Adjuvant therapy with high-dose interferon alpha 2b in patients with high-risk stage IIB/III melanoma.
PMID 18030300·Nat Clin Pract Oncol·2008
8-other
Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations.
PMID 16609054·Clin Cancer Res·2006
6-review
A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma.
PMID 15014018·Clin Cancer Res·2004
3-trial
Adjuvant high-dose interferon-alpha therapy for high-risk melanoma.
PMID 14732880·Forum (Genova)·2003
6-review
Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690.
PMID 12209697·Cancer·2002
3-trial
Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy.
PMID 12202672·J Clin Oncol·2002
6-review
High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801.
PMID 11331315·J Clin Oncol·2001
3-trial
High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696.
PMID 11230488·J Clin Oncol·2001
3-trial
High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.
PMID 10856105·J Clin Oncol·2000
3-trial
Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma.
PMID 10870051·Cancer·2000
3-trial
Liquid crystalline collagen: a self-assembled morphology for the orientation of mammalian cells.
PMID 19437784·Langmuir·2009
7-preclinical
Differentiation of group I and group II strains of Clostridium botulinum by focal plane array Fourier transform infrared spectroscopy.
PMID 17066916·J Food Prot·2006
4-observational
Unusual mortality incidents in tit species (family Paridae) associated with the novel bacterium Suttonella ornithocola.
PMID 16474055·Vet Rec·2006
7-preclinical
Suttonella ornithocola sp. nov., from birds of the tit families, and emended description of the genus Suttonella.
PMID 16280481·Int J Syst Evol Microbiol·2005
7-preclinical
Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008.
PMID 19659612·Pigment Cell Melanoma Res·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5150 CENTRE AVE, 2ND FLOOR
PITTSBURGH, PA 15232 - Phone
- (412) 692-4724
Quick Facts
- NPI
- 1528036449
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 53
- Publications
- 20
Are you this provider?
Claim Your Profile